Taking the time to verify your benefits and work with your doctor to document medical necessity can make a big difference in getting the support you need for your health journey
A statement late last year from the Obesity Action Center called on the Kentucky legislature to remove the Medicaid ban on obesity medications to give health care providers a tool to manage this chronic condition that affects more than 34% of adults in the state, costing the state an estimated $36 billion annually
Neurogan's answer to that complexity is a question back to the consumer: what if the ingredient doing the work didn't need 28 others to support it
5-HT 4 receptor agonists Prucalopride, a selective 5-hydroxytryptamine 4 (5-HT 4 ) receptor agonist, was effective in improving symptoms in a cohort with predominantly idiopathic gastroparesis, but despite accelerating gastric emptying in a diabetes-specific group, did not improve symptoms [73]
upregulates VEGF, BDNF, and BMP-2 expression
The sNDA was based on results from the Phase 3, double-blind, parallel-group, placebo-controlled cardiovascular outcomes trial, SOUL. The trial reported a 14% reduction in the risk of MACE compared to placebo when added to standard of care in patients with T2DM and established CVD and/or CKD